Vilin Bio Med

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0L4V01013
  • NSEID: VILINBIO
  • BSEID:
INR
52.30
0.00 (0.00%)
BSENSE

Sep 24, 03:30 PM

BSE+NSE Vol: 4000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 185.37% vs -6.30% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 305.79% vs -3.66% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -91.86% vs 7.55% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 762.66% vs 37.68% in Mar 2025

Compare Profit and Loss Results of Vilin Bio Med
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
42.00
45.00
-3.00
-6.67%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
42.00
45.00
-3.00
-6.67%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
37.00
0.00
37.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
8.00
-8.00
-100.00%
Operating Expenses
0.00
13.00
-13.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
7.00
-7.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
39.00
32.00
7.00
21.88%
Operating Profit (PBDIT) excl Other Income
3.00
12.00
-9.00
-75.00%
Other Income
0.00
2.00
-2.00
-100.00%
Operating Profit (PBDIT)
3.00
15.00
-12.00
-80.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
3.00
15.00
-12.00
-80.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
2.00
15.00
-13.00
-86.67%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
2.00
15.00
-13.00
-86.67%
Provision for Tax
0.00
3.00
-3.00
-100.00%
Profit After Tax
1.00
11.00
-10.00
-90.91%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
12.00
-12.00
-100.00%
Profit Available for appropriations
2.00
23.00
-21.00
-91.30%
Appropriations
2.00
23.00
-21.00
-91.30%
Equity Dividend (%)
0%
5%
-5.00
Earnings Per Share
1.26
5.71
-4.45
-77.93%
Profit And Loss - Net Sales
Net Sales 42.26 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 185.37% vs -6.30% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.19 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 305.79% vs -3.66% in Mar 2025

Profit And Loss - Interest
Interest 0.07 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -91.86% vs 7.55% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 1.93 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 762.66% vs 37.68% in Mar 2025

Footer loading